Search for Clinical Trial Results
Leukemia, Mast-Cell - 25 Studies Found
Status | Study |
Completed |
Study Name: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant Condition:
Interventions: |
Active, not recruiting |
Study Name: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer Condition:
Interventions: |
Recruiting |
Study Name: Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Condition:
Interventions: Other: cytology specimen collection procedure Correlative studies |
Completed |
Study Name: Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy Condition:
|
Terminated |
Study Name: Sunitinib in Treating Patients With Idiopathic Myelofibrosis Condition:
Interventions: Drug: sunitinib malate Given PO |
Active, not recruiting |
Study Name: Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer Condition:
Interventions: |
Completed |
Study Name: Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer Condition:
Interventions: |
Active, not recruiting |
Study Name: Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies Condition:
|
Active, not recruiting |
Study Name: Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer Condition:
Interventions: |
Completed |
Study Name: Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) Condition:
Date: 2007-06-26 Interventions: Drug: Ontak (Denileukin Diftitox) 9 µg/kg by vein Days 1-5 of a 21 day cycle. |